Comparing the Stanford Letter Project Form to Traditional Advance Directives

Last updated: April 4, 2024
Sponsor: Stanford University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer Treatment

Cancer

Treatment

Randomized clinical study

Clinical Study ID

NCT02799537
36786
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Over 18 years of age

Exclusion

Exclusion Criteria:

  • Under 18

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Randomized clinical study
Phase:
Study Start date:
February 01, 2016
Estimated Completion Date:
December 31, 2026

Study Description

Step1: Any adult participant who is interested in completing advance directives and able to read and write in English and or Spanish will be eligible to participate in the study

Step 2:

Online Stanford consent form will be presented before the participants. Only after they read the consent and click on the participation link will they be able to enter the study.Those who are willing to participate will be randomly assigned to either the letter or traditional advance directives in Spanish and study measures. They will also answer questions as to how much they liked and understood the documents.

Step 4: The investigators will collect data until the investigators reach an n=1000

Step 5: The investigators will analyze the results and submit for publication.

In this protocol, we are assessing whether patients prefer the traditional advance directives or the letter directive. As it is just an questionnaire based study, there no risk for patients.

Connect with a study center

  • Stanford School of Medicine

    Stanford, California 94305
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.